FABTECH147.10

Fabtech Technologies Limited

· Pharma & Health
₹ CrorePeersLAXMIDENTLTARSONSFISCHERGKBMcap ₹654 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt42.742.7
Net Debt-53.9-53.9
Total Debt/Equity0.100.10
Net Debt/Equity-0.13-0.13
Total Debt/EBITDA1.221.22
Net Debt/EBITDA-1.54-1.37
Interest Coverage (EBIT/Interest)7.147.14
Total Debt/Total Capital %9.249.24
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.